TY - JOUR
T1 - Non-β-oxidizable ω-[18F]fluoro long chain fatty acid analogs show cytochrome P-450-mediated defluorination
T2 - Implications for the design of PET tracers of myocardial fatty acid utilization
AU - Degrado, Timothy R.
AU - Moka, Detlef C.
PY - 1992/4
Y1 - 1992/4
N2 - The nature of the in vivo defluorination of non-β-oxidizable no-carrier-added ω-[18F]fluoro long chain fatty acid (LCFA) analogs was studied with the aim of developing PET tracers of LCFA utilization. Extensive defluorination of 15-[18F]fluoro-3-thia-pentadecanoic acid (FTPA) in mouse was evidenced by radioactivity uptake by bone. [18F]Fluoride in the blood was verified analytically. Incubations of FTPA in rat-liver homogenates and subcellular fractions thereof showed a strong defluorination process in microsomes which was O2- and NADPH-dependent. In contrast, defluorination of FTPA was relatively slow in Langendorff perfused rat heart. High bone uptake in mouse was also observed with 14-[18F]fluoro-13, 13-dimethyl-3-thia-tetradecanoic acid, where gem-dimethyl substitution precludes direct elimination of H18F. These data indicate that the defluorination of non-β-oxidizable ω-[18F]fluoro LCFA analogs is primarily governed by cytochrome P-450-mediated ω-oxidation. Therefore, labeling at the (ω-3) carbon was proposed to provide a more stabile 18F-label. Defluorination of the (ω-3)-labeled 13 (R,S)-[18F]fluoro-3-thia-hexadecanoic acid was lower than that of FTPA in mouse and was independent of O2 and NADPH in vitro. Thus, (ω-3) labeling with 18F is preferable to ω labeling of non-β-oxidizable LCFA analogs.
AB - The nature of the in vivo defluorination of non-β-oxidizable no-carrier-added ω-[18F]fluoro long chain fatty acid (LCFA) analogs was studied with the aim of developing PET tracers of LCFA utilization. Extensive defluorination of 15-[18F]fluoro-3-thia-pentadecanoic acid (FTPA) in mouse was evidenced by radioactivity uptake by bone. [18F]Fluoride in the blood was verified analytically. Incubations of FTPA in rat-liver homogenates and subcellular fractions thereof showed a strong defluorination process in microsomes which was O2- and NADPH-dependent. In contrast, defluorination of FTPA was relatively slow in Langendorff perfused rat heart. High bone uptake in mouse was also observed with 14-[18F]fluoro-13, 13-dimethyl-3-thia-tetradecanoic acid, where gem-dimethyl substitution precludes direct elimination of H18F. These data indicate that the defluorination of non-β-oxidizable ω-[18F]fluoro LCFA analogs is primarily governed by cytochrome P-450-mediated ω-oxidation. Therefore, labeling at the (ω-3) carbon was proposed to provide a more stabile 18F-label. Defluorination of the (ω-3)-labeled 13 (R,S)-[18F]fluoro-3-thia-hexadecanoic acid was lower than that of FTPA in mouse and was independent of O2 and NADPH in vitro. Thus, (ω-3) labeling with 18F is preferable to ω labeling of non-β-oxidizable LCFA analogs.
UR - http://www.scopus.com/inward/record.url?scp=44049122409&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44049122409&partnerID=8YFLogxK
U2 - 10.1016/0883-2897(92)90124-H
DO - 10.1016/0883-2897(92)90124-H
M3 - Article
C2 - 1629027
AN - SCOPUS:44049122409
SN - 0883-2897
VL - 19
SP - 389
EP - 397
JO - International Journal of Radiation Applications and Instrumentation.
JF - International Journal of Radiation Applications and Instrumentation.
IS - 3
ER -